Groups Con. (μmol/L) Function1 Expression2 MDR1 mRNA levels3
Blank control - 648.82 ± 9.23 28.75 ± 6.25 1.04 ± 0.25
Curcumin 0.1 608.52 ± 7.52* 114.16 ± 5.52* 1.58 ± 0.10*
0.5 504.24 ± 7.13* 126.01 ± 4.53* 1.60 ± 0.08*
1 429.31 ± 8.30* 133.13 ± 5.58·* 1.62 ± 0.05*
Tetrahydrocurcumin 0.5 562.52 ± 6.54* 106.32 ± 5.10* 1.32 ± 0.09*
1 486.72 ± 8.93* 117.88 ± 6.38* 1.35 ± 0.06*
5 380.74 ± 7.85* 124.93 ± 3.87* 1.36 ± 0.04*
Rifampicin 10 195.82 ± 5.98* 148.75 ± 4.99* 1.74 ± 0.27*
Plasma samples - 250.02 ± 10.18*# — —
CsA 5 982.28 ± 10.25·* 19.59 ± 3.11* 0.66 ± 0.07*·
1The intracellular fluorescence of Rh-123;
2Protein expression of p-gp;
3Relative MDR1 mRNA levels of p-gp (ratio of MDR1 mRNA levels and mRNA levels of the internal reference β-actin);
*P<0.05 versus blank control group;
#P<0.05 versus curcumin and tetrahydrocurcumin groups
Table 2: The concentration-dependent induction of p-gp function, expression and relative MDR1 mRNAs levels by curcumin and tetrahydrocurcumin. The blank control group was treated with PBS buffer (means ± SD, n=5).
Goto home»